Racial and ethnic differences in medications for opioid use disorder and overdose in 11 state Medicaid programs from 2016 to 2020

By afschroeder • March 7, 2026

Donohue J, Wang B, Tang L, Kim JY, Junker S, Cole E, Chang CH, Roberts E, Wilson JD, Essien U, Gifford K, Hammerslag L, Talbert J, Ahrens K, Idala D, Mohamoud S, Clark S, Austin A, Ware O, Tossone K, Mack A, Fry C, Gordon AJ, Barnes A, Marks S, Cunningham P, Allen L, Burns M, Kennedy S. Racial and ethnic differences in medications for opioid use disorder and overdose in 11 state Medicaid programs from 2016 to 2020. J Subst Use Addict Treat. 2026 Mar 4:209924. doi: 10.1016/j.josat.2026.209924. Epub ahead of print. PMID: 41791553.

Tags: buprenorphine, General Internal Medicine, medicaid, Medication for opioid-use disorder, methadone, naltrexone, Overdose, Publications, Racial/ethnic differences, Veterans Administration

The Journey of the “Asthmanaut”: Communicating Dyspnea Through Poetry

Tsevat RK, Campo R. The Journey of the "Asthmanaut": Communicating Dyspnea Through Poetry. JAMA. 2026 Mar 25. doi: 10.1001/jama.2026.1511. Epub ahead of print. PMID: 41879768.

Minimal Clinically Important Difference of the Sinonasal Outcome Test in Sinonasal Malignancy

Maoz SL, Lee M, Fischer JL, Choby G, Hwang PH, Wang EW, Kuan EC, Adappa ND, Geltzeiler M, Getz AE, Humphreys IM, Le CH, Pinheiro-Neto[...]

An enigmatic rash: When the obvious isn’t

Ragaisis T, Kingsley T. An enigmatic rash: When the obvious isn't. JAAPA. 2026 Apr 1;39(4):45-47. doi: 10.1097/01.JAA.0000000000000333. Epub 2026 Mar 24. PMID: 41874093.